{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T09:18:58Z","timestamp":1787735938129,"version":"build-2784847793"},"reference-count":41,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,8,26]],"date-time":"2027-08-26T00:00:00Z","timestamp":1819238400000},"content-version":"am","delay-in-days":359,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG075335"],"award-info":[{"award-number":["R01AG075335"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["1RF1AG063381-01"],"award-info":[{"award-number":["1RF1AG063381-01"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.hrthm.2026.04.019","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T23:26:56Z","timestamp":1776468416000},"page":"e1937-e1946","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patterns of antithrombotic treatment after left atrial appendage occlusion"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6429-5982","authenticated-orcid":false,"given":"Xiaojuan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Schneeweiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Kevin","family":"Heist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Avorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4564-3715","authenticated-orcid":false,"given":"Kueiyu Joshua","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2026.04.019_bib1","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2026.04.019_bib2","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart disease and stroke Statistics-2019 update: A report from the American Heart Association","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2026.04.019_bib3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jacc.2013.08.1631","article-title":"Left atrial appendage occlusion: opportunities and challenges","volume":"63","author":"Holmes","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2026.04.019_bib4","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.117.005359","article-title":"Percutaneous left atrial appendage closure: current devices and clinical outcomes","volume":"10","author":"Asmarats","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.hrthm.2026.04.019_bib5","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.mayocp.2018.09.025","article-title":"Left atrial appendage occlusion for the unmet clinical needs of stroke prevention in nonvalvular atrial fibrillation","volume":"94","author":"Holmes","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.hrthm.2026.04.019_bib6","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1016\/j.jacc.2018.04.013","article-title":"Stroke prevention in nonvalvular atrial fibrillation: A stakeholder perspective","volume":"71","author":"Alkhouli","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2026.04.019_bib7","doi-asserted-by":"crossref","first-page":"e1086","DOI":"10.1016\/j.hrthm.2025.07.051","article-title":"Left atrial appendage closure vs oral anticoagulation for stroke prevention in atrial fibrillation: long-term outcomes from 4 randomized trials","volume":"22","author":"Kaisaier","year":"2025","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2026.04.019_bib8","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial","volume":"374","author":"Holmes","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2026.04.019_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial","volume":"64","author":"Holmes","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2026.04.019_bib10","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.jcin.2023.01.011","article-title":"SCAI\/HRS expert consensus statement on transcatheter left atrial appendage closure","volume":"16","author":"Saw","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.hrthm.2026.04.019_bib11","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.hrthm.2017.05.038","article-title":"Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-year follow-up outcome data of the EWOLUTION trial","volume":"14","author":"Boersma","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2026.04.019_bib12","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.4244\/EIJ-D-16-00726","article-title":"Transcatheter left atrial appendage occlusion in patients with atrial fibrillation and a high bleeding risk using aspirin alone for post-implant antithrombotic therapy","volume":"12","author":"Korsholm","year":"2017","journal-title":"EuroIntervention"},{"key":"10.1016\/j.hrthm.2026.04.019_bib13","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.jacc.2022.02.047","article-title":"Antithrombotic therapy after left atrial appendage occlusion in patients with atrial fibrillation","volume":"79","author":"Freeman","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2026.04.019_bib14","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.123.010279","article-title":"Patient characteristics associated with using transcatheter left atrial appendage occlusion versus oral anticoagulants for atrial fibrillation","volume":"17","author":"Lin","year":"2024","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.hrthm.2026.04.019_bib15","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jclinepi.2010.10.004","article-title":"A combined comorbidity score predicted mortality in elderly patients better than existing scores","volume":"64","author":"Gagne","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.hrthm.2026.04.019_bib16","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/gerona\/gly197","article-title":"Validation of a claims-based frailty index against physical performance and adverse health outcomes in the health and retirement study","volume":"74","author":"Kim","year":"2019","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.hrthm.2026.04.019_bib17","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/pds.2109","article-title":"An automated database case definition for serious bleeding related to oral anticoagulant use","volume":"20","author":"Cunningham","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.hrthm.2026.04.019_bib19","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/europace\/euz258","article-title":"EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update","volume":"22","author":"Glikson","year":"2020","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2026.04.019_bib20","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1161\/CIRCULATIONAHA.120.050117","article-title":"Primary outcome evaluation of a next-generation left atrial appendage closure device: results from the PINNACLE FLX trial","volume":"143","author":"Kar","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2026.04.019_bib21","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/CIRCULATIONAHA.121.057063","article-title":"Amplatzer amulet left atrial appendage occluder versus Watchman device for stroke prophylaxis (amulet IDE): A randomized, controlled trial","volume":"144","author":"Lakkireddy","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2026.04.019_bib22","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.123.013750","article-title":"Outcomes with the Watchman FLX in everyday clinical practice from the NCDR left atrial appendage occlusion registry","volume":"17","author":"Kapadia","year":"2024","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.hrthm.2026.04.019_bib24","doi-asserted-by":"crossref","first-page":"e1048","DOI":"10.1016\/j.hrthm.2025.05.048","article-title":"2025 SCAI\/HRS clinical practice guidelines on transcatheter left atrial appendage occlusion","volume":"22","author":"Goldsweig","year":"2025","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2026.04.019_bib25","first-page":"2914","article-title":"Left atrial appendage closure for stroke prevention in atrial fibrillation: current status and perspectives","volume":"45","author":"Landmesser","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2026.04.019_bib26","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1016\/j.jcin.2023.08.013","article-title":"DAPT is comparable to OAC following LAAC with Watchman FLX: A National registry analysis","volume":"16","author":"Coylewright","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.hrthm.2026.04.019_bib27","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/europace\/euaa074","article-title":"Initial and long-term antithrombotic therapy after left atrial appendage closure with the WATCHMAN","volume":"22","author":"Ledwoch","year":"2020","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2026.04.019_bib28","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.3390\/jcm10091959","article-title":"Role of different antithrombotic regimens after percutaneous left atrial appendage occlusion: A large Single Center experience","volume":"10","author":"Mazzone","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.hrthm.2026.04.019_bib29","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijcard.2022.09.066","article-title":"Looking for optimal antithrombotic strategy after transcatheter left atrial appendage occlusion: a real-world comparison of different antiplatelet regimens","volume":"371","author":"Vignali","year":"2023","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2026.04.019_bib30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.amjcard.2020.08.013","article-title":"Safety and efficacy of Single versus Dual antiplatelet therapy after left atrial appendage occlusion","volume":"134","author":"Patti","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2026.04.019_bib31","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.hrthm.2024.11.035","article-title":"Reduced direct oral anticoagulant dose vs dual antiplatelet therapy after left atrial appendage closure in patients with nonvalvular atrial fibrillation: a systematic review and meta-analysis","volume":"22","author":"Lima","year":"2025","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2026.04.019_bib32","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.120.009691","article-title":"Racial disparities in in-hospital adverse events among patients with atrial fibrillation implanted with a Watchman left atrial appendage occlusion device: a US National perspective","volume":"14","author":"Khan","year":"2021","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2026.04.019_bib33","doi-asserted-by":"crossref","first-page":"e2421","DOI":"10.1212\/WNL.0000000000007534","article-title":"Oral anticoagulation in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"92","author":"Malhotra","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.hrthm.2026.04.019_bib34","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1136\/gutjnl-2021-325184","article-title":"Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update","volume":"70","author":"Veitch","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.hrthm.2026.04.019_bib35","first-page":"E111","article-title":"Device-associated thrombus formation after left atrial appendage occlusion: a systematic review of events reported with the Watchman, the Amplatzer Cardiac Plug and the Amulet","volume":"90","author":"Lempereur","year":"2017","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.hrthm.2026.04.019_bib36","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.jacc.2018.01.076","article-title":"Device-related thrombosis after percutaneous left atrial appendage occlusion for atrial fibrillation","volume":"71","author":"Fauchier","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2026.04.019_bib37","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1093\/eurheartj\/ehaa169","article-title":"Left atrial appendage occlusion with the Amplatzer\u2122 Amulet\u2122 device: full results of the prospective global observational study","volume":"41","author":"Hildick-Smith","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2026.04.019_bib38","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1016\/j.jcin.2023.10.046","article-title":"Device-related thrombus after left atrial appendage occlusion: clinical impact, predictors, classification, and management","volume":"16","author":"Alkhouli","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.hrthm.2026.04.019_bib39","doi-asserted-by":"crossref","first-page":"e590","DOI":"10.4244\/EIJ-D-18-00344","article-title":"Left atrial appendage occlusion with the AMPLATZER Amulet device: one-year follow-up from the prospective global Amulet observational registry","volume":"14","author":"Landmesser","year":"2018","journal-title":"EuroIntervention"},{"key":"10.1016\/j.hrthm.2026.04.019_bib40","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jacep.2022.03.001","article-title":"Clinical impact of residual leaks following left atrial appendage occlusion: insights from the NCDR LAAO registry","volume":"8","author":"Alkhouli","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2026.04.019_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2025.102019","article-title":"Comparing claims data to stroke and bleeding in the NCDR left atrial appendage occlusion registry","volume":"4","author":"Faridi","year":"2025","journal-title":"JACC Adv"},{"key":"10.1016\/j.hrthm.2026.04.019_bib42","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.hrthm.2024.12.007","article-title":"Single vs dual antiplatelet therapy after left atrial appendage closure: a propensity score matching analysis","volume":"22","author":"Galea","year":"2025","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2026.04.019_bib43","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jacc.2024.05.067","article-title":"Anticoagulation alone vs anticoagulation plus aspirin or DAPT following left atrial appendage occlusion","volume":"84","author":"Reinhardt","year":"2024","journal-title":"J Am Coll Cardiol"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527126022691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527126022691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T08:36:45Z","timestamp":1787733405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527126022691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1547527126022691"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2026.04.019","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patterns of antithrombotic treatment after left atrial appendage occlusion","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2026.04.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Heart Rhythm Society. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}